 Trial Duration of Treatment : Patients will receive study drug for about 12 weeks. Patients may be able to receive MK-0646 for as long as 1 year if it seems to be stopping the growth of their cancer and not causing bad side effects. If the patient has a complete response to MK-0646, they may receive up to 8 additional weeks of treatment. 